At a glance
ClinicalIndex Comparison RecordN/ACompleted· 676 enrolled
Drug / intervention
T80/A5/H12.5 FDCdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Special Drug Use-results Survey on Long-term Use of Telmisartan 80 mg/Amlodipine 5 mg/Hydrochlorothiazide 12.5 mg Fixed Dose Combination Tablets in Patients With Hypertension
In Brief
An observational study evaluating T80/A5/H12.5 FDC for Hypertension. Completed, enrolled 676 participants across 1 site.
Detailed Summary
Study to evaluate real-world safety, effectiveness and appropriate use of Micatrio® Combination Tablets treatment in patients with hypertension
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHypertension
CountriesJapan
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJan 2017
Enrollment StartJan 2017
Primary CompletionApr 2019
TodayJul 2026
First PostedJan 13, 2017
Enrollment StartJan 20, 2017
Primary CompletionApr 11, 2019
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 9.5 years ago
Interventions
T80/A5/H12.5 FDCdrug
Drug